Title:
CETP阻害薬及びHMG-CoA還元酵素阻害薬を含有する剤形
Document Type and Number:
Japanese Patent JP2006512359
Kind Code:
A
Abstract:
A dosage form comprises (1) a solid amorphous dispersion comprising a cholesterol ester transfer protein inhibitor and an acidic concentration-enhancing polymer and (2) an HMG-CoA reductase inhibitor. The solid amorphous dispersion and the HMG-CoA reductase inhibitor are combined in the dosage form so that the solid amorphous dispersion and the HMG-CoA reductase inhibitor are substantially separate from one another in the dosage form.
More Like This:
Inventors:
Friesen, Dwayne Thomas
Lorenz, Douglas Alan
Rion, David Keith
Hancock, Bruno Casper
McDermott, Timothy Joseph
Shanker, Rabi Mysore
Lorenz, Douglas Alan
Rion, David Keith
Hancock, Bruno Casper
McDermott, Timothy Joseph
Shanker, Rabi Mysore
Application Number:
JP2004561902A
Publication Date:
April 13, 2006
Filing Date:
December 12, 2003
Export Citation:
Assignee:
Pfizer Products Inc.
International Classes:
A61K45/06; A61K9/08; A61K9/14; A61K9/16; A61K9/20; A61K9/24; A61K9/48; A61K31/00; A61K31/40; A61K31/4706; A61K47/38; A61P3/06; A61P43/00
Domestic Patent References:
JP2002532409A | 2002-10-02 |
Foreign References:
WO2000038722A1 | 2000-07-06 | |||
WO2002100394A1 | 2002-12-19 | |||
US6310075B1 | 2001-10-30 | |||
WO2002013797A2 | 2002-02-21 | |||
WO2002011710A2 | 2002-02-14 | |||
WO2001093860A1 | 2001-12-13 |
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazumi Nakamura
Masaya Nishiyama
Takashi Ishida
Fukumoto product
Tetsuji Koga
Kazumi Nakamura
Masaya Nishiyama